Treatment of Age-Related Macular Degeneration

Klein R. , Klein B.E.K. , Linton K.L.P. Prevalence of age related maculopathy, The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933–43

Mitchell P. , Smith W. , Attebo K. , Wang J.J. Prevalence of age related maculopathy in Australia. Ophthalmology 1995; 102: 145060

Vingerling J.R. , Dielemans I. , Hofman A. . The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995; 102: 205–10

Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomised clinical trials. Arch Ophthalmol 1991; 109: 1109–14

Macular Photocoagulation Study Group. Recurrent choroidal neovascularisation after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986; 104: 503–12

Chopdar A. , Chakravarthy U. , Verma D. Age related macular degeneration. BMJ 2003; 326: 485–8

A randomised, placebo-controlled clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No 8. Arch Ophthalmol 2001; 119: 1417–36

Young R.W. Solar radiation and age related macular degeneration. Surv Ophthalmol 1988; 32: 252–69

Beatty S. , Koh H. , Phil M. , Henson D. , Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115–34

Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200–9

Sickenberg M. , Schmidt-Erfurth U. , Miller J.W. . A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularisation in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000; 117: 327–36

Photodynamic therapy of subfoveal choroidal neovascularisation in age related macular degeneration with verteporfin. One year results of 2 randomised clinical trials—TAP report 1. Arch Ophthalmol 1999; 117: 1329–45

Photodynamic therapy of subfoveal choroidal neovascularization in age related macular degeneration with verteporfin. Two year results of 2 randomised clinical trials—TAP report 2. Arch Ophthalmol 2001; 119: 198–207

Photodynamic therapy of subfoveal choroidal neovascularization in age related macular degeneration with verteporfin. Three year results of an open label extension of 2 randomised clinical trials—TAP report No 5. Arch Ophthalmol 2002; 120: 1307–14

Verteporfin therapy of subfoveal choroidal neovascularization in age related macular degeneration: two-year results of a randomised clinical trial including lesions with occult with no classic choroidal neovascularisation—verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541–60

Sharma S. Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularisation secondary to age related macular degeneration. Can J Ophthalmol 2001; 36: 7–10

Sharma S. , Brown G.C. , Brown M.M. , Hollands H. , Shah G.K. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Ophthalmology 2001; 108: 2051–9

Meads C. , Sales C. , Roberts T. , Moore D. , Fry-Smith A. , Hyde C. Clinical Effectiveness and Cost Utility of Photodynamic Therapy for Wet Age-related Macular Degeneration. Birmingham: West Midlands Technology Assessment Group, University of Birmingham, 2002

Fujii G.Y. , De Juan E. , Pieramici D.J. . Inferior limited macular translocation for subfoveal choroidal neovascularisation: 1-year visual outcome and recurrence report. Am J Ophthalmol 2002; 134: 69–74

Aisenbrey S. , Lafaut B. , Szurman P. . Macular translocation with 360° retinotomy for exudative age related macular degeneration. Arch Ophthalmol 2002; 120: 451–9

Ciulla T.A. Recent advances in the treatment of exudative age related macular degeneration, including transpupillary thermotherapy. Acta Ophthalmol Scand 2003; 81: 103–4

Algvere P.V. , Libert C. , Lindgarde G. , Seregard S. Transpupillary thermotherapy of predominantly occult choroidal neovascularisation in age related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003; 81: 110–17

Krzystolik M.G. , Afshari M.A. , Adamis A.P. . Prevention of experimental choroidal neovascularisation with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002; 120: 338–46

The Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration, phase II study results. Ophthalmol 2003; 110: 979–86

The Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for treatment of subfoveal neovascularisation in age related macular degeneration: twelve-month clinical outcomes. Ophthalmology 2003; 110: 2372–85

Gillies M.C. , Simpson J.M. , Luo W. . A randomised clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age related macular degeneration. Arch Ophthalmol 2003; 121: 667–73